Dengue virus envelope protein domain I/II hinge determines long-lived serotype-specific dengue immunity. - Wikidata - awgldk - TriplyDB

Dengue virus envelope protein domain I/II hinge determines long-lived serotype-specific dengue immunity.

Dengue virus envelope protein domain I/II hinge determines long-lived serotype-specific dengue immunity.

http://www.wikidata.org/entity/Q37571377

about

MEPPitope: spatial, electrostatic and secondary structure perturbations in the post-fusion Dengue virus envelope protein highlights known epitopes and conserved residues in the Zika virus Rapid isolation of dengue-neutralizing antibodies from single cell-sorted human antigen-specific memory B-cell cultures Dengue Fever: Causes, Complications, and Vaccine Strategies A high-throughput shotgun mutagenesis approach to mapping B-cell antibody epitopes The Complexity of a Dengue Vaccine: A Review of the Human Antibody Response Dengue E Protein Domain III-Based DNA Immunisation Induces Strong Antibody Responses to All Four Viral Serotypes Molecular engineering and plant expression of an immunoglobulin heavy chain scaffold for delivery of a dengue vaccine candidate A broadly neutralizing human monoclonal antibody is effective against H7N9.Chimeric GII.4 norovirus virus-like-particle-based vaccines induce broadly blocking immune responses.Dengue serotype cross-reactive, anti-e protein antibodies confound specific immune memory for 1 year after infection.Utility, limitations, and future of non-human primates for dengue research and vaccine development Dengue virus neutralizing antibody levels associated with protection from infection in thai cluster studies.Isolation of dengue virus-specific memory B cells with live virus antigen from human subjects following natural infection reveals the presence of diverse novel functional groups of antibody clones.Variation of the specificity of the human antibody responses after tick-borne encephalitis virus infection and vaccination.Novel recombinant chimeric virus-like particle is immunogenic and protective against both enterovirus 71 and coxsackievirus A16 in mice.Antibodies against immature virions are not a discriminating factor for dengue disease severity.Dengue viruses are enhanced by distinct populations of serotype cross-reactive antibodies in human immune sera.Immunogenicity and efficacy of flagellin-envelope fusion dengue vaccines in mice and monkeys.Complexity of Neutralizing Antibodies against Multiple Dengue Virus Serotypes after Heterotypic Immunization and Secondary Infection Revealed by In-Depth Analysis of Cross-Reactive Antibodies Isolation and Characterization of Broad and Ultrapotent Human Monoclonal Antibodies with Therapeutic Activity against Chikungunya Virus.Dengue virus antibody database: Systematically linking serotype-specificity with epitope mapping in dengue virus.Trends in Dengue Cases Imported into the United States from Pan America 2001-2012 Molecular Basis of the Divergent Immunogenicity of Two Pediatric Tick-Borne Encephalitis Virus Vaccines.A game of numbers: the stoichiometry of antibody-mediated neutralization of flavivirus infection.Dengue serotype immune-interactions and their consequences for vaccine impact predictions Human antibodies stop dengue virus by jamming its mechanics.The relevance of dengue virus genotypes surveillance at country level before vaccine approval.Low frequency of broadly neutralizing HIV antibodies during chronic infection even in quaternary epitope targeting antibodies containing large numbers of somatic mutations.Complexity of Human Antibody Response to Dengue Virus: Implication for Vaccine Development.Use of a Recombinant Gamma-2 Herpesvirus Vaccine Vector against Dengue Virus in Rhesus Monkeys.Dengue virus envelope protein domain I/II hinge: a key target for dengue virus vaccine design?Structures and Functions of the Envelope Glycoprotein in Flavivirus Infections.

P2860

Q26700001-2B19C683-AD79-45C1-B8CA-5F5C3F184987 Q26700070-E77EC29A-F47A-4BEE-BEF0-94A165EE5D0F Q26700082-1220F849-DA47-42D4-B044-7CFEBDF13A22 Q26860116-41764B63-BB75-4EC9-B8AD-27C75A5BF300 Q26995782-E07B85DB-E96E-41CD-A02C-8F77BCF7A10C Q27304342-75E9B247-AC1A-4A82-B96C-53712D3EA46B Q29587283-C1AF6082-EBB9-4BA3-8C72-7977B162B820 Q30378035-CF8680F9-F555-40C6-BB42-532A718629E0 Q33743992-34505534-F413-404E-8E93-006110E20D9D Q34042859-5BEDF3D6-AD0C-4C38-B956-AF7F9C1A35F0 Q34238916-2FDB8C5E-70F5-4C2D-A3AA-72DD5CA67B81 Q34351011-9B4971E5-F16D-4D42-939F-6E90E86B36A9 Q34593818-6188938B-07A2-4B54-AD69-0ECAEEA1D5F7 Q34594111-EEBAAA69-A407-48ED-ACA1-A1598B608DDC Q34981056-B3E24726-016E-4C00-8CDD-787DE303CA59 Q35168403-C7E49FAB-24E6-47DC-AD93-61864C6FE2C2 Q35294150-3FA3A2E3-F60E-4AC4-87A9-8953289DB0BB Q35548048-D4DC59DF-8176-4519-A15C-26C9FDB625AB Q35758626-102FEF16-C04A-45D6-B379-877CD9DB9E16 Q35850197-83EC5E66-5935-4639-9917-C299B3D42EAB Q36286276-A595D48E-9244-4BD7-B055-8AE71DB8DBF4 Q36444531-0053A403-53E8-4463-8430-C56A5F50E88A Q36524044-809A7B8B-9216-4D14-9B8A-136C1A7A0AD3 Q37012203-F2AB948A-8EF8-4128-A984-89987F18E121 Q37270826-6F5FDCCF-2B02-4C6D-B750-BAC6B4FD170A Q37571400-C2866C24-9621-4930-B3DE-4C7B659AC689 Q38284671-25B4FB54-F827-4987-959B-08BF8115C2E2 Q38589314-2069EE22-CA51-48BE-9FCC-6509E87593F5 Q39535403-1DCB3AFD-F4FA-49F6-B179-49DC8216AE7F Q40053434-AB8793CF-C86D-4633-A615-97E5485B4288 Q43038900-4621BD70-E9D4-4DC6-98F4-44E39AEE3CA2 Q46261471-588A436E-F0A7-4F9E-B6C9-945C39695695

P2860

Dengue virus envelope protein domain I/II hinge determines long-lived serotype-specific dengue immunity.

http://www.wikidata.org/entity/Q37571377

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 02 January 2014

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Dengue virus envelope protein ...... type-specific dengue immunity.

@en

Dengue virus envelope protein ...... type-specific dengue immunity.

@nl

type

label

Dengue virus envelope protein ...... type-specific dengue immunity.

@en

Dengue virus envelope protein ...... type-specific dengue immunity.

@nl

prefLabel

Dengue virus envelope protein ...... type-specific dengue immunity.

@en

Dengue virus envelope protein ...... type-specific dengue immunity.

@nl

P1433

Q37571377-0979752D-D902-4D7D-9BB0-E4A7C622131D

P1476

Q37571377-F4F3DF59-B326-46FD-869C-38AC1CEF9B27

P2093

Q37571377-2ECE0BDF-450C-45E4-8193-79FF478A9570

Q37571377-318C6741-3649-4B31-95AB-87359A2A6124

Q37571377-4217D38F-C83F-4B4A-9DD0-974AF896C353

Q37571377-5B1B5B02-BB54-495F-9444-5E820021EF73

Q37571377-91A18E00-40E0-4022-B294-3976C3E597E4

Q37571377-936F3489-B49A-4379-8466-B077B44096C8

Q37571377-A3A3922E-C225-444E-B033-6A70630CBA90

Q37571377-A77693BF-6D95-4617-BF30-C71BACB85B69

Q37571377-B5FDBB4F-A1C2-44F8-ADC5-8DA2CAE39E9A

Q37571377-CB637331-BE16-4259-A22F-CB62B0EFE67C

P2860

Q37571377-0195C376-4BDF-43E5-9061-73A8DF763768

Q37571377-02A06A01-FB0B-48BC-906B-248773E77090

Q37571377-14CD37D7-46DF-4D5E-BDC6-001B9E30CA74

Q37571377-19EABAF6-CA52-4E70-B38F-DD508B2CA7C4

Q37571377-1FE87163-6258-4149-8BE9-A6508C527676

Q37571377-21F70EB6-B901-496B-9118-E924FB1B9BF3

Q37571377-373FB079-2279-4B15-9F9E-EBA3E5D1A5AD

Q37571377-3CBB8E87-E14C-46EC-AB0F-EB0C78055CB5

Q37571377-4EBD9A9A-1DCC-4B6B-8E4A-982B0652C527

Q37571377-52BD77E6-C66D-46B1-BE87-61D2E268AE85

P304

Q37571377-DD41CF53-08FB-4A69-AF4A-A3E4D73D6F12

P31

Q37571377-05E0F09E-9292-4C45-AA3C-D0C0FFBE7D51

P356

Q37571377-B1D1DEE4-B387-480F-892C-946B36E2EE45

P407

Q37571377-8A03827E-B9F1-4167-AB27-B1865CE098BE

P433

Q37571377-A5BB876C-798A-49C4-83C6-8A70EF9B19FB

P478

Q37571377-9E5097BE-779F-4880-9ACC-2D3C0E3FF8FE

P50

Q37571377-2EA47951-0720-4141-AEDB-5DC37DB5FE5F

Q37571377-DC8994A0-BE77-4267-963C-0CF6A54C8E8E

Q37571377-E8D96B67-37F8-4C86-99E3-8D0890097728

Q37571377-EF3C519E-F064-4F2A-BA6A-EF2EF25E94CB

P577

Q37571377-24112764-F37A-43D6-B259-0F950336962A

P5875

Q37571377-7FE1611F-9E83-4E9D-9053-E4EB5B4369FD

P698

Q37571377-927C66FB-D5DD-489C-8187-31BB3B9C1931

P921

Q37571377-A7C735E0-898B-44F8-B81D-B96F2D1AC985

P932

Q37571377-BE521703-29C4-42B9-B40C-155921BAC97E

P356

PNAS.1317350111

P1433

Proceedings of the National Academy of Sciences of the United States of America

P1476

Dengue virus envelope protein ...... type-specific dengue immunity.

@en

P2093

Benjamin J Doranz

http://www.w3.org/2001/XMLSchema#string

Boyd L Yount

http://www.w3.org/2001/XMLSchema#string

Carlos A Sariol

http://www.w3.org/2001/XMLSchema#string

Jennifer M Pfaff

http://www.w3.org/2001/XMLSchema#string

Jeremy P Huynh

http://www.w3.org/2001/XMLSchema#string

Kristen M Kahle

http://www.w3.org/2001/XMLSchema#string

Laura J White

http://www.w3.org/2001/XMLSchema#string

Ruklanthi de Alwis

http://www.w3.org/2001/XMLSchema#string

Scott A Smith

http://www.w3.org/2001/XMLSchema#string

Scott R Royal

http://www.w3.org/2001/XMLSchema#string

P2860

Atomic-level mapping of antibody epitopes on a GPCR

The global distribution and burden of dengue

Multiple sequence alignment with the Clustal series of programs

A ligand-binding pocket in the dengue virus envelope glycoprotein

Comparison of Plaque- and Flow Cytometry-Based Methods for Measuring Dengue Virus Neutralization

Human Monoclonal Antibodies against West Nile Virus Induced by Natural Infection Neutralize at a Postattachment Step

Dengue virus neutralization by human immune sera: Role of envelope protein domain III-reactive antibody

Structure of the dengue virus envelope protein after membrane fusion

Neutralization of West Nile virus by cross-linking of its surface proteins with Fab fragments of the human monoclonal antibody CR4354

Influenza Human Monoclonal Antibody 1F1 Interacts with Three Major Antigenic Sites and Residues Mediating Human Receptor Specificity in H1N1 Viruses

P304

1939-1944

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1073/PNAS.1317350111

http://www.w3.org/2001/XMLSchema#string

P407

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

111

http://www.w3.org/2001/XMLSchema#string

P50

Aravinda de Silva

James E. Crowe Jr.

Ruklanthi de Alwis

P577

2014-01-02T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

259566959

http://www.w3.org/2001/XMLSchema#string

P698

24385585

http://www.w3.org/2001/XMLSchema#string

P921

P932

3918811

http://www.w3.org/2001/XMLSchema#string